Serologic Screening for Genital Herpes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

JAMA. 2023 Feb 14;329(6):510-512. doi: 10.1001/jama.2022.20356.
No abstract available

Plain language summary

This systematic review to support the 2023 US Preventive Services Task Force Recommendation Statement on serologic screening for genital herpes summarizes published evidence on the benefits and harms of screening and interventions for genital herpes in asymptomatic sexually active adolescents, adults, and pregnant persons with no clinical history of genital herpes.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Systematic Review

MeSH terms

  • Advisory Committees
  • Herpes Genitalis* / blood
  • Herpes Genitalis* / diagnosis
  • Herpes Genitalis* / prevention & control
  • Humans
  • Mass Screening*
  • Serologic Tests*
  • United States